Growth Metrics

Edwards Lifesciences (EW) Net Income (2016 - 2025)

Edwards Lifesciences has reported Net Income over the past 17 years, most recently at $27.0 million for Q4 2025.

  • For Q4 2025, Net Income fell 31.3% year-over-year to $27.0 million; the TTM value through Dec 2025 reached $13.4 million, down 99.52%, while the annual FY2025 figure was $13.4 million, 99.52% down from the prior year.
  • Net Income for Q4 2025 was $27.0 million at Edwards Lifesciences, up from -$2.0 million in the prior quarter.
  • Over five years, Net Income peaked at $2.7 billion in Q3 2024 and troughed at -$7.2 million in Q1 2025.
  • A 5-year average of $289.7 million and a median of $51.4 million in 2023 define the central range for Net Income.
  • Biggest five-year swings in Net Income: skyrocketed 5447.75% in 2024 and later crashed 540.0% in 2025.
  • Year by year, Net Income stood at $335.3 million in 2021, then crashed by 40.2% to $200.5 million in 2022, then plummeted by 81.75% to $36.6 million in 2023, then increased by 7.38% to $39.3 million in 2024, then tumbled by 31.3% to $27.0 million in 2025.
  • Business Quant data shows Net Income for EW at $27.0 million in Q4 2025, -$2.0 million in Q3 2025, and -$4.4 million in Q2 2025.